KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Net Cash Flow (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Net Cash Flow for 17 consecutive years, with -$13.0 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 93.75% to -$13.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$133.0 million through Dec 2025, down 2.31% year-over-year, with the annual reading at -$133.0 million for FY2025, 2.31% down from the prior year.
  • Net Cash Flow hit -$13.0 million in Q4 2025 for Quest Diagnostics, down from $115.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $543.0 million in Q4 2023 to a low of -$670.0 million in Q2 2021.
  • Historically, Net Cash Flow has averaged -$36.8 million across 5 years, with a median of -$69.5 million in 2022.
  • Biggest five-year swings in Net Cash Flow: plummeted 322.22% in 2022 and later soared 2800.0% in 2024.
  • Year by year, Net Cash Flow stood at -$115.0 million in 2021, then tumbled by 234.78% to -$385.0 million in 2022, then skyrocketed by 241.04% to $543.0 million in 2023, then plummeted by 138.31% to -$208.0 million in 2024, then soared by 93.75% to -$13.0 million in 2025.
  • Business Quant data shows Net Cash Flow for DGX at -$13.0 million in Q4 2025, $115.0 million in Q3 2025, and $127.0 million in Q2 2025.